Search results
FDA Panel to Consider Updating COVID-19 Jabs for New Virus Strains
Zacks via Yahoo Finance· 4 days agoAn FDA panel meeting is scheduled on Jun 5 to consider if COVID-19 vaccines should be updated to...
Adults 60+ Will Have 3 RSV Vaccines to Choose From This Year
Verywell Health via Yahoo News· 3 days agoThat way, you can have some time between shots before it’s time to get your fall flu shot and an...
Singapore slams opposition claims linking Covid vaccines to excess deaths
South China Morning Post· 4 days agoThe health ministry said it categorically rejected the egregious and false claims, adding that...
Fighting Words in a COVID-19 Pandemic—Combating an Era of Denialism
Newsweek· 2 days agoHippocrates tells us, "Primum non nocere," or "First do no harm." Recent testimony in Congress has...
A promising vaccine approach to induce longer-lasting protective immunity against COVID-19
Medical Xpress· 4 days agoIn an ongoing, four-year collaboration, the team leveraged a novel vaccine platform to fuse the...
COVID vaccine makers ready updated shots for fall immunization drive (NYSE:PFE)
Seeking Alpha· 3 days agoPfizer (PFE), BioNTech (BNTX), Moderna (MRNA) and Novavax (NVAX) reaffirm commitment to provide...
FDA Advisors Give a Hearty Thumbs Up to a COVID Vaccine Based on the JN.1 Strain
MedPage Today· 3 days agoAn FDA advisory committee voted unanimously, 16-0, Wednesday to recommend that the COVID-19 vaccines...
Quick Takes: US COVID-19 levels, H5N1, and Polio
Center for Infectious Disease Research and Policy· 14 hours agoThe last data from the CDC show upticks in early COVID-19 indicators, but severity indicators remain unchanged from the previous week.
mRESVIA’s FDA approval paves the way for mRNA vaccines across multiple indications
Clinical Trials Arena via Yahoo Finance· 2 days agoModerna’s respiratory syncytial virus (RSV) vaccine mRESVIA has received US Food and Drug...
Moderna's MMA candidate nabs spot in FDA pilot for rare disease drugs
FierceBiotech· 1 day agoModerna’s methylmalonic acidemia candidate, mRNA-3705, will be developed under the FDA’s START pilot...